M.V.I. ADULT retinol ergocalciferol .alpha.-tocopherol acetate dl- phytonadione ascorbic acid niacinamide riboflavin 5-phosphate

Ország: Egyesült Államok

Nyelv: angol

Forrás: NLM (National Library of Medicine)

Aktív összetevők:

RETINOL (UNII: G2SH0XKK91) (RETINOL - UNII:G2SH0XKK91)

Beszerezhető a:

Hospira Worldwide, Inc.

INN (nemzetközi neve):

RETINOL

Összetétel:

RETINOL 1 mg in 5 mL

Recept típusa:

PRESCRIPTION DRUG

Engedélyezési státusz:

New Drug Application

Termékjellemzők

M.V.I. ADULT- RETINOL, ERGOCALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE,
DL-, PHYTONADIONE, ASCORBIC
ACID, NIACINAMIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, THIAMINE
HYDROCHLORIDE, PYRIDOXINE
HYDROCHLORIDE, DEXPANTHENOL, BIOTIN, FOLIC ACID, AND CYANOCOBALAMIN
HOSPIRA, INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
M.V.I.-ADULT™ SAFELY AND EFFECTIVELY. SEE FULL
PRESCRIBING INFORMATION FOR M.V.I.-ADULT™.
M.V.I.-ADULT™ (MULTI-VITAMIN INJECTION), FOR INTRAVENOUS USE.
INITIAL U.S. APPROVAL: 2004
INDICATIONS AND USAGE
M.V.I.-Adult™ is a combination of vitamins indicated for prevention
of vitamin deficiency in adults and children aged 11
years and above receiving parenteral nutrition (1)
DOSAGE AND ADMINISTRATION
•
•
•
•
•
•
•
•
DOSAGE FORMS AND STRENGTHS
•
•
•
CONTRAINDICATIONS
•
•
WARNINGS AND PRECAUTIONS
•
•
•
•
•
•
•
M.V.I.-Adult™ is a combination product that contains the following
vitamins: ascorbic acid, vitamin A, vitamin D,
thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin
E, vitamin K, folic acid, biotin, and vitamin B
(2.1)
12
Recommended daily dosage is 10 mL (2.2)
M.V.I.-Adult™ is for administration by intravenous infusion after
dilution (2.1)
M.V.I.-Adult™ is supplied as single dose and as a pharmacy bulk
package:
•
•
M.V.I.-ADULT™ SINGLE DOSE consists of two vials labeled Vial 1 and
Vial 2. Transfer contents of Vial 1 to Vial
2. The mixed solution (10 mL) will provide a single 10 mL dose (2.1,
2.3)
M.V.I.-ADULT™ PHARMACY BULK PACKAGE consists of two vials labeled
Vial 1 and Vial 2. Transfer the
contents of Vial 1 to Vial 2. The mixed solution (100 mL) will provide
ten 10 mL single doses to patients in a
pharmacy admixture program (2.1, 2.3)
Prior to Intravenous administration, dilute the once daily dose of 10
mL by adding to at least 500 to 1000 mL
intravenous parenteral nutrition solution containing dextrose or
saline (2.3)
After dilution in an intravenous infusion